We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+16.13%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$118M
AUM Growth
–
Cap. Flow
+$110M
Cap. Flow
% of AUM
93.29%
Top 10 Holdings %
Top 10 Hldgs %
44.14%
Holding
66
New
66
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$8.71M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
+$5.1M |
| 3 |
TEAR
TearLab Corporation
TEAR
|
+$5.07M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$4.68M |
| 5 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$4.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.21% |
| 2 | Consumer Staples | 3.12% |
| 3 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AtriCure
ATRC
$1.92B
| $11.2M | 9.49% |
+599,048
| New | +$8.71M |
|
|
SPNC
2
DELISTED
Spectranetics Corp
SPNC
| $5.95M | 5.04% |
+238,004
| New | +$5.1M |
|
|
SRGA
3
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.97M | 4.22% |
+46,839
| New | +$4.54M |
|
|
TEAR
4
DELISTED
TearLab Corporation
TEAR
| $4.75M | 4.03% |
+50,883
| New | +$5.07M |
|
|
LCI
5
DELISTED
Lannett Company, Inc.
LCI
| $4.65M | 3.94% |
+35,136
| New | +$3.72M |
|
6
QuidelOrtho
QDEL
$1.14B
| $4.36M | 3.69% |
+141,030
| New | +$3.62M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $4.31M | 3.65% |
+860,066
| New | +$4.68M |
|
|
AKRX
8
DELISTED
Akorn Inc
AKRX
| $4.24M | 3.6% |
+172,275
| New | +$3.89M |
|
9
NeoGenomics
NEO
$1.96B
| $3.97M | 3.36% |
+1,095,701
| New | +$3.8M |
|
|
STKL
10
DELISTED
SunOpta
STKL
| $3.68M | 3.12% |
+367,280
| New | +$3.54M |
|
|
STRM
11
DELISTED
Streamline Health Solutions
STRM
| $3.42M | 2.9% |
+32,714
| New | +$3.59M |
|
|
VOLC
12
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $3.31M | 2.81% |
+151,638
| New | +$3.36M |
|
13
Omnicell
OMCL
$1.61B
| $3.18M | 2.69% |
+124,441
| New | +$2.97M |
|
14
Ligand Pharmaceuticals
LGND
$5.76B
| $3.17M | 2.69% |
+96,568
| New | +$3.15M |
|
|
ACCL
15
DELISTED
Accelrys Inc
ACCL
| $2.99M | 2.53% |
+313,204
| New | +$2.94M |
|
16
Celldex Therapeutics
CLDX
$2.99B
| $2.81M | 2.38% |
+7,740
| New | +$2.98M |
|
|
NVDQ
17
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.81M | 2.38% |
+170,082
| New | +$2.82M |
|
18
STAAR Surgical
STAA
$1.21B
| $2.66M | 2.25% |
+164,021
| New | +$2.19M |
|
19
Standard BioTools
LAB
$340M
| $2.23M | 1.89% |
+58,175
| New | +$1.71M |
|
|
CPHD
20
DELISTED
Cepheid Inc
CPHD
| $2.09M | 1.77% |
+44,854
| New | +$1.9M |
|
21
Alkermes
ALKS
$8.22B
| $2.08M | 1.77% |
+51,228
| New | +$1.89M |
|
|
NPSP
22
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.07M | 1.76% |
+68,245
| New | +$1.88M |
|
23
HealthStream
HSTM
$819M
| $1.95M | 1.66% |
+59,827
| New | +$2.05M |
|
|
ABCO
24
DELISTED
Advisory Board Co
ABCO
| $1.82M | 1.54% |
+28,550
| New | +$1.82M |
|
|
ARTC
25
DELISTED
ARTHROCARE CORP
ARTC
| $1.77M | 1.5% |
+44,010
| New | +$1.63M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for First Light Asset Management, which disclosed 66 positions worth $118M. Its ten largest holdings account for 44% of the portfolio.
Its largest position is AtriCure: 599,048 shares worth $11.2M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, followed by Consumer Staples and Financials.
- First Light Asset Management's largest Q4 2013 buy was AtriCure: 599,048 shares worth $11.2M.
- First Light Asset Management's ten largest holdings make up 44% of its $118M portfolio in Q4 2013.
- First Light Asset Management disclosed 66 positions in Q4 2013, its first 13F filing on record.
Based on First Light Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.